Telehealth partners for Eli Lilly (LLY) continue to sell compounded GLP-1 weight-loss drugs despite an agreement with the ...

Trump administration officials are expected to release more details on their plan to lower prescription drug prices in the ...

Wall Street investors closely monitoring trade discussions between the US and China drove stocks higher as Commerce Secretary ...

While pharmaceutical executives raise valid concerns about the lack of detailed implementation plans for the “Most Favored ...

WASHINGTON — Trump administration officials are expected to release more details on their plan to lower prescription drug ...

(Reuters) -Talks with the Trump administration about lowering U.S. drug prices have so far not provided clarity on when and ...

In JAMA, the FDA's Makary and Prasad said they will focus on modernizing review processes and lowering drug costs but don't outright mention precision medicine.

As President Donald Trump vows to bridge the drug pricing gap between the U.S. and other developed countries with his “most ...

These companies own 97% of the weight loss drug market -- which could grow tenfold over the next decade -- and are developing ...

Companies are always in the race for the top spot, and the only way to achieve it is by reaching a high market valuation. The ...

Ron Lanton, Partner, Lanton Law, weighs in on the potential international trade, pricing, and access implications of tying US drug costs to those in other developed countries under the Most Favored ...

Eli Lilly and Company thrives on its groundbreaking weight-loss drug tirzepatide. Learn why we could see a $50B market and ...